Skip to main content
Go to home pagemRNA Access Logo

Resources

Featured Resources
Video

Moderna Seminar Series. Chapter 1: Intro to mRNA Medicine

  • February 9, 2022
  • 22:41
Webinar Series
hp-banner-video-mobile
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Journal Article

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

  • August 1, 2020
  • Nature
Categories: mRNA Vaccines, Preclinical
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Nature 586 (7830) October 22, 2020
Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease
Journal Article

Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease

  • November 30, 2017
  • Journal of Infectious Diseases
Categories: Global Health, mRNA Vaccines, Preclinical
Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease
The Journal of Infectious Diseases 217 (3) February 1 2018
Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
Journal Article

Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice

  • July 1, 2019
  • Journal of Infectious Diseases
Categories: Global Health, mRNA Vaccines, Preclinical
Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
Journal of Infectious Diseases 220 (10) November 15 2019
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Journal Article

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

  • May 1, 2019
  • Vaccine
Categories: Clinical, mRNA Vaccines, Preclinical
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Vaccine 39 (44) 22 October 2021
Video

Moderna Seminar Series. Chapter 2: Basic mRNA Biology

  • February 9, 2022
  • 12:39
Categories: Webinar Series
Melissa Moore Webinar Chapter 2

Explore All Resources

Explore resources by selecting a category of your choice

Clear Filter

mrna vaccines
mRNA Vaccines
global health
Global Health
icon-mrna science
mRNA Science
delivery science
Delivery Science
preclinical
Preclinical
clinical
Clinical
Icon Webinar
Webinar Series

Interested in mRNA Access?

Partner with us to bring this global health initiative to life.

By submitting your information, you agree to Moderna’s Terms and Conditions. You also acknowledge that your information will be processed in accordance with Moderna’s Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Services apply.